Publication | Closed Access
lissoclin Disulfoxide, A Novel Dimeric Alkaloid from the Ascidian<i>lissoclinum</i>Sp.: Inhibitor of Interleukin-8 Receptors
19
Citations
4
References
1997
Year
Pharmaceutical ScienceImmunologyInterleukin-8 ReceptorsPharmacotherapyMeoh ExtractPharmaceutical ChemistryInflammationMolecular PharmacologyMedicinal ChemistryLissoclin DisulfoxideBiochemistryBioassay-guided IsolationMechanism Of ActionNatural Product SynthesisPharmacologyAnti-inflammatoryNatural SciencesAbstract Bioassay-guided FractionationMedicineDrug Discovery
Abstract Bioassay-guided fractionation of the MeOH extract of the South African ascidian Lissoclinum sp. yielded three known compounds plus a novel alkaloid, lissoclin disulfoxide (1), whose structure was determined by interpretation of spectral data. Alkaloid 1 had IC50 values of 0.6 and 0.82 μM against the inhibition of IL-8 Rα and IL-8 Rβ receptors, respectively.
| Year | Citations | |
|---|---|---|
Page 1
Page 1